SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
4,602.00    16.00 (0.35%)
Bid:
4,600.00
Ask:
4,604.00
Spread: 4.00 (0.087%)
Market Cap: £16.77b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Directorate Change

22 Jun 2016 08:13

RNS Number : 9181B
Coca-Cola HBC AG
22 June 2016
 

 

 

FOR IMMEDIATE RELEASE

Coca-Cola HBC AG

Composition of the Committees of the Board of Directors of Coca-Cola HBC AG and determination of new members of the Board of Directors of Coca-Cola HBC AG

 

Zug, Switzerland - 22 June 2016 - Coca-Cola HBC AG ("Coca-Cola HBC" or the "Company") announces today that its board of directors (the "Board") has appointed Mr. William W. Douglas III as chairman of the Audit Committee and Mr. Reto Francioni as the chairman of the Nomination Committee and a member of the Remuneration Committee, with effect from 21 June 2016. These appointments have been made pursuant to the announcement released by Coca-Cola HBC on 17 May 2016 and the election of Messrs. Ahmet C. Bozer, William (Bill) W. Douglas III, Reto Francioni and Robert Ryan Rudolph as non-executive members of the Board at the Company's annual general meeting held on 21 June 2016, following the retirement of Mr. George David, Mr. Irial Finan, Sir Michael Llewellyn Smith and Mr. Nigel Macdonald.

 

The Board has also resolved that Mr. Reto Francioni is appointed as the Senior Independent Director of the Company.

 

The Board has determined that Messrs. Bill Douglas and Reto Francioni qualify as independent under the criteria set forth in the UK Corporate Governance Code. The Board considers the other newly appointed non-executive directors, Messrs. Ahmet C. Bozer and Robert Ryan Rudolph, not to be independent for purposes of the UK Corporate Governance Code, due to existing business relationships with Coca-Cola HBC's major shareholders, The Coca-Cola Company and Kar-Tess Holding.

 

Aside from the information set out above, no further information is required to be disclosed pursuant to the UK Financial Conduct Authority's Listing Rule 9.6.13 and none of the new non-executive directors hold any interests in the shares of Coca-Cola HBC.

 

This announcement is made pursuant to Listing Rule 9.6.11.

 

Enquiries

Coca‑Cola HBC Group

Basak Kotler

Investor Relations Director

Tel: +41 41 726 0143

 basak.kotler@cchellenic.com

 

Nikos Efstathopoulos

Investor Relations Manager

Tel: +30 210 618 3260

 nikos.efstathopoulos@cchellenic.com

Caroline Crampton

Investor Relations Manager

caroline.crampton@cchellenic.com

 

International media contact:

Teneo

Rob Morgan

Ben Ullmann

Anushka Mathew

Tel: +44 20 7240 2486

 robert.morgan@teneostrategy.com

 ben.ullmann@teneostrategy.com

 anushka.mathew@teneostrategy.com

 

Greek media contact:

V+O Communications

Argyro Oikonomou

Tel: +30 211 7501219

 ao@vando.gr

 

 

About Coca‑Cola HBC

Coca-Cola HBC is a leading bottler of The Coca-Cola Company with a sales volume of more than 2 billion unit cases. It has a broad geographic footprint with operations in 28 countries serving a population of approximately 594 million people. Coca-Cola HBC offers a diverse range of non-alcoholic ready to drink beverages in the sparkling, juice, water, sport, energy, tea and coffee categories. Coca-Cola HBC is committed to promoting sustainable development in order to create value for its business and for society. This includes providing products that meet the beverage needs of consumers, fostering an open and inclusive work environment, conducting its business in ways that protect and preserve the environment and contribute to the socio-economic development of the local communities. Coca-Cola HBC is ranked beverage industry leader in the Dow Jones Sustainability World and Europe Indices, and is also included in the FTSE4Good Index.

 

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and its shares are listed on the Athens Exchange (ATHEX: EEE). For more information, please visit http://www.coca-colahellenic.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOALIFLDRIIFFIR
Date   Source Headline
22nd May 20263:30 pmRNSDirector/PDMR Shareholding
19th May 20263:15 pmRNSDirector/PDMR Shareholding
11th May 20269:00 amRNSDirector Declaration
8th May 20263:15 pmRNSComposition of the Board Committees
8th May 20263:10 pmRNSResult of AGM
7th May 20267:00 amRNSStrong volume drives Q1 sales growth
20th Apr 20263:15 pmRNSDirector/PDMR Shareholding
14th Apr 202612:15 pmRNSNotice of Results
2nd Apr 20267:00 amRNSNotice of AGM, changes to the BoD, dividend dates
1st Apr 20269:15 amRNSTransfer of treasury shares & total voting rights
31st Mar 202611:00 amRNSPublication of Final Terms
27th Mar 20262:45 pmRNSDirector/PDMR Shareholding
27th Mar 20262:15 pmRNSDirector/PDMR Shareholding
26th Mar 20266:18 pmRNSPricing of Issue of Notes
26th Mar 20269:05 amRNSLaunch of Issue of Notes
25th Mar 20261:36 pmRNSPublication of a Prospectus
20th Mar 202611:00 amRNSAnnual Financial Report
19th Mar 20264:55 pmRNSDirector/PDMR Shareholding
19th Mar 20264:45 pmRNSDirector/PDMR Shareholding
18th Mar 20264:15 pmRNSDirector/PDMR Shareholding
18th Mar 202611:35 amRNSDirector/PDMR Shareholding
26th Feb 202611:30 amRNSDirector/PDMR Shareholding
25th Feb 20269:20 amRNSDirector/PDMR Shareholding
24th Feb 20264:55 pmRNSDirector/PDMR Shareholding
24th Feb 20264:50 pmRNSDirector/PDMR Shareholding
23rd Feb 20264:40 pmRNSDirector/PDMR Shareholding
23rd Feb 20264:35 pmRNSDirector/PDMR Shareholding
18th Feb 20264:50 pmRNSDirector/PDMR Shareholding
18th Feb 20264:45 pmRNSDirector/PDMR Shareholding
18th Feb 20264:00 pmRNSDirector/PDMR Shareholding
17th Feb 20263:35 pmRNSDirector/PDMR Shareholding
17th Feb 20263:30 pmRNSDirector/PDMR Shareholding
16th Feb 20262:40 pmRNSDirector/PDMR Shareholding
16th Feb 20262:35 pmRNSDirector/PDMR Shareholding
13th Feb 202610:30 amRNSDirector/PDMR Shareholding
12th Feb 20263:45 pmRNSDirector/PDMR Shareholding
12th Feb 20261:15 pmRNSDirector/PDMR Shareholding
10th Feb 20267:00 amRNSStrong execution and financial performance in 2025
2nd Feb 202610:00 amRNSTransfer of treasury shares & total voting rights
19th Jan 20264:00 pmRNSDirector/PDMR Shareholding
19th Jan 20262:20 pmRNSResult of Extraordinary General Meeting
13th Jan 202611:00 amRNSNotice of Results
5th Jan 202610:00 amRNSDirector/PDMR Shareholding
23rd Dec 20252:45 pmRNSDirector/PDMR Shareholding
23rd Dec 20252:45 pmRNSDirector/PDMR Shareholding
22nd Dec 20252:15 pmRNSDirector/PDMR Shareholding
22nd Dec 20252:15 pmRNSDirector/PDMR Shareholding
18th Dec 20255:00 pmRNSDirector/PDMR Shareholding
18th Dec 20255:00 pmRNSDirector/PDMR Shareholding
18th Dec 20253:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.